key: cord-0729296-4yuc83a6
authors: Marconi, Vincent C.; Krishnan, Venkatesh; Ely, E. Wesley; Montano, Monty
title: Immune Health Grades: Finding Resilience in the COVID-19 Pandemic and Beyond
date: 2021-11-02
journal: J Allergy Clin Immunol
DOI: 10.1016/j.jaci.2021.10.025
sha: 1c77e0f9d81b1511b01519ff66354f6b6ef71e78
doc_id: 729296
cord_uid: 4yuc83a6

nan

With over 225 million cases of SARS-CoV-2 infection and more than 4,650,000 deaths from COVID-19 23 worldwide, identifying those individuals at risk of severe disease becomes an incredibly valuable pursuit 24 when resources are limited, and medical care is costly. Several COVID-19 risk measures have  25  demonstrated substantial predictive capacity for severe COVID-19 and death including the Veterans  26 Health Administration COVID-19 (VACO) Index for COVID-19 Mortality 1 . This well-validated index utilizes 27 age, gender, and pre-existing comorbidities to estimate risk of 30-day mortality in inpatients and 28 outpatients after SARS-CoV2 infection. COVID-19 has enabled the scientific community to reexamine risk 29 stratification with a comprehensive vision of disease susceptibility that leverages deep immunologic 30 data. 31

In this issue, Dr. Lee and colleagues described a novel attribute termed "immunologic resilience" (IR) to 32 predict COVID-19 disease severity and death independent of age, while also informing outcomes for 33 individuals with other infectious and non-infectious diseases 2 . To initially characterize IR, the investigators proposed four immune health grades (IHGs) and evaluated 43 their distribution within ten non-COVID-19 cohorts (N=13,389 patients) with a diverse history of 44 antigenic (infectious) exposures. These cohorts include Framingham, SardiNIA, several influenza cohorts, 45 a Lupus cohort, the U.S. Military HIV Natural History Study, and healthcare workers exposed to SARS-46

CoV-2. Thereafter, the IHGs were applied to 522 hospitalized and non-hospitalized patients with SARS-47

CoV-2 infection. The primary endpoint was 30-day mortality while 120-day mortality, hospitalization, 48 length of stay, respiratory progression, and several biomarkers were examined as robust secondary 49 endpoints. 50

The framework for IHGs was based on the principle that the equilibrium between peripheral blood CD8+ 51

and CD4+ T-cell counts is a more precise metric of IR than either alone. The metric uses a CD4+/CD8+ 52 ratio stratified at 1.0, followed hierarchically by the CD4 count at 800 cells/µL with further sub-53 stratifications below this threshold resulting in eight IHG categories. IHG-I was designated as the ideal IR 54 category with a ratio >1.0 and CD4 count >800 cells/µL. This group was most common overall and over-55

represented in the SardiNIA cohort, women, asymptomatic HIV infection, and in non-severe COVID-19. 56

Compared with the SardiNIA cohort, IHG-I was substantially under-represented (21% versus 73%, 57 p<0.001), while IHG-II and IHG-IV were substantially over-represented (64% vs. 22% and 13% vs. 3% 58 respectively, p<0.001) among patients with COVID-19. Although IHG-I appears to decline with age in the 59

SardiNIA cohort, this decline is speculated to be driven by life history exposure to pathogens rather than 60 chronological aging ( Figure 1A ). In addition to pathogen exposure, other environmental (e.g. diet, 61 radiation) and genetic (i.e. intrinsic capacity) factors influence the rate of this decline. If correct, this may 62 suggest, as the authors note, that age is an imperfect proxy for antigenic experience and raises the 63 possibility that a metric for antigenic life history might be more informative for disease trajectory than 64 chronological age alone. The degradation of IHG-I was generally associated with chronological aging and 65 may, in part, reflect immunosenescence: both as a generic decline in immune function with aging as well 66

as an outcome of cellular senescence. From this perspective, chronic exposure to antigens driving loss in 67 IHG-I may represent a novel "gerodriver" that has been underappreciated in the field of geroscience, 68

and especially in the context of immune aging. Because the SardiNIA cohort is a somewhat genetically 69 homogeneous population, albeit well-characterized immunologially 3 , it will be essential to "pressure 70

test" the generalizability of the IHGs in demographically distinct populations. 71

In The finding that autoantibodies against Type I interferons and related dysfunction in interferon receptor 89 signaling in responsive neutrophils can cause increased risk of SARS-CoV-2, underscores the importance 90 of IR 4 . These results are consistent with key observations of dysfunctional neutrophils, excess immature 91 monocytes, and dysfunctional natural killer cells along with a reduction in antigen presenting dendritic 92 cells in patients with severe COVID-19 5 ( Figure 1B) . Evaluation of sera from a range of mild to severe 93 COVID-19, revealed that systemic biomarkers correlated with these aberrant cells were dysregulated. 94

Furthermore, changes in these biomarkers correlated with changes in ordinal scale, suggesting a 95 hyperinflammatory stage that leads to severe complications in COVID-19. These markers included 96 cytokines such as IL-6, MCP-3, and their signaling may be attenuated by interventions such as 97 corticosteroids, Jak inhibitors, and IL-6 blockade. Notably serum markers associated with robust antigen 98 presenting dendritic cells (TRANCE, SCF, FLT3L etc.) were reduced in these patients along with increases 99 in markers that associate with vascular inflammation (CTSL1, PTX-3, IL-6 etc.) 6 . 100

The viral expansion phase in COVID-19 occurs prior to symptom presentation and continues as patients 101

progress to more severe disease states. The IR was robust in patients that experienced mild symptoms. 102

One feature of innate immunity is a subset of NK cells expressing KLDR1 which respond to the influenza 103

virus. Presence of these cells may predict increased IR and protect from severe symptoms in influenza 7 . 104

The observation that serum SCF was significantly reduced in severe COVID-19 patients may suggest that 105 early NK cell development is compromised in severe patients. Collectively, these findings support the 106 increased role played by the viral load-driven increase in inflammatory cytokines, in moderate to severe 107 COVID-19. Anti-inflammatory interventions for COVID-19 will be tasked with balancing the reduction in 108 sequelae from the increased inflammatory burden while maintaining robust viral clearance pathways. 109

This delicate balance is required to engage crucial adaptive responses that offer long-term protection. 110

The opportunity to survey biomarkers and sensitive assessments of viral load such as droplet PCR, from 111 vaccinated individuals with break-through infections and compare to unvaccinated individuals exposed 112

to SARS-CoV-2 may help explore the importance of vaccination in IR. These longitudinal analyses may 113 converge on features of the immune system and serve as a bellwether for a variety of infections across 114

populations. 115

Since ideal IR was exemplified by IHG-I and an IC hi -IF lo state, and transcriptomic data supported the 116 transition from IHG-I to other states, independently of age, it will be interesting to see whether 117

geroscience-focused clinical studies (e.g., the TAME trial and others) will benefit from measuring 118 associations between IHGs and comorbid burden. Importantly, while the authors have begun cross-119 validating their scoring system with earlier immune age signatures (e.g., IMM-AGE) 8 , it will be important 120 to see how the IHG system complements newer approaches (e.g., iAGE) 9 . 121

A key question going forward will be to better understand antecedent conditions that lead to the 122 differing IHG states. Because collection of samples was initiated at presentation to the hospital, this 123 makes inference of IR -prior to infection -difficult to predict and will likely require longitudinal sampling 124 of other ongoing COVID-19 natural history studies that include pre-infection sampling, and ideally deep 125 immune phenotyping, including systems serotyping which was not conducted in this study. Also, prior 126 studies have identified epigenetic imprinting, termed "trained immunity" in response to prior 127 infections 10 . Whether historic antigenic exposure trains IHGs will be important to ascertain in future 128 studies. Because the primary outcomes were 30-day mortality, whether IHGs are informative for post-129 acute COVID-19 sequelae is currently unclear. Finally, whether pathogen-specific signatures can be 130 found that inform treatment of patients towards an IHG-I state remains to be determined. 131

Beyond COVID-19, there remains a need for a contextual holistic understanding of immunologic 132 vulnerability that could explain the heterogeneity observed in multiple disease manifestations 133 throughout the aging process. In this elegant study, immunologic resilience was defined as a capacity to 134 preserve and restore immunocompetence and to control inflammation in the face of pathogenic 135 challenges throughout life, with the immunocompetence high -inflammation low phenotype as a resilience 136

hallmark. As such, the immune health grade system is a pragmatic clinical tool for staging, monitoring, 137 differential diagnosis, and potentially directed therapies. This study provides a new lens for 138 understanding immune aging in terms of immunologic life history, and further, that resilience to these 139 exposures can be categorized into health grades. This newly defined dialectic interaction between 140 immunocompetence and inflammation in an immunologic resilience fitness landscape that is shaped by 141 person or population history of antigenic exposure is a testable model that will no doubt influence the 142 discussion and interpretation of pathogenic trajectories and treatment strategies going forward. 143

Development and 145 validation of a 30-day mortality index based on pre-existing medical administrative data from 146 13,323 COVID-19 patients: The Veterans Health Administration COVID-19 (VACO) Index

Immunologic 149 resilience and COVID-19 survival advantage

Unravelling the complex genetic regulation of immune cells

Global absence and targeting of 154 protective immune states in severe COVID-19

Deep immune profiling 156 of COVID-19 patients reveals distinct immunotypes with therapeutic implications

Characterization of the 159 cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19

KLRD1-expressing natural killer cells predict influenza 162 susceptibility

A clinically 164 meaningful metric of immune age derived from high-dimensional longitudinal monitoring

An inflammatory 167 aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and 168 cardiovascular aging